Harmony Biosciences to report Q2 2026 results on August 4
Harmony Biosciences Holdings, Inc. will announce its Q2 2026 financial results on August 4, 2026, before market open. A conference call and webcast will follow at 8:30 a.m. ET, accessible via domestic and international dial-in numbers.
*this image is generated using AI for illustrative purposes only.
Harmony Biosciences Holdings, Inc. will report its second quarter 2026 financial results on Tuesday, August 4, 2026, before the open of U.S. financial markets. The company will host a conference call and webcast at 8:30 a.m. ET to discuss the results.
Investors can participate in the call by dialing 800-347-6865 for domestic access or 203-518-9757 for international or alternate access, using passcode HRMYQ226. Participants are advised to dial in at least 10 minutes prior to the start time.
A live and replay webcast of the call will be available on the investor page of Harmony Biosciences' website at https://ir.harmonybiosciences.com/ .
Conference Call Details
| Detail | Information |
|---|---|
| Date | August 4, 2026 |
| Time | 8:30 a.m. ET |
| Domestic Dial-in | 800-347-6865 |
| International Dial-in | 203-518-9757 |
| Passcode | HRMYQ226 |
| Webcast | https://ir.harmonybiosciences.com/ |
Harmony Biosciences is a pharmaceutical company focused on developing and commercializing therapies for patients with rare neurological diseases. The company was established by Paragon Biosciences, LLC, in 2017 and is headquartered in Plymouth Meeting, Pa.
What key performance indicators should investors focus on during the Q2 2026 earnings call?
How might the financial results impact Harmony Biosciences' stock price immediately following the announcement?
What updates on ongoing clinical trials or new therapies could be disclosed during the call?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
